These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 21419610)

  • 1. Short- and long-term exposure of articular cartilage to curcumin or quercetin inhibits aggrecan loss.
    Lay E; Samiric T; Handley CJ; Ilic MZ
    J Nutr Biochem; 2012 Feb; 23(2):106-12. PubMed ID: 21419610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinguishing aggrecan loss from aggrecan proteolysis in ADAMTS-4 and ADAMTS-5 single and double deficient mice.
    Ilic MZ; East CJ; Rogerson FM; Fosang AJ; Handley CJ
    J Biol Chem; 2007 Dec; 282(52):37420-8. PubMed ID: 17938173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast growth factor 2 inhibits induction of aggrecanase activity in human articular cartilage.
    Sawaji Y; Hynes J; Vincent T; Saklatvala J
    Arthritis Rheum; 2008 Nov; 58(11):3498-509. PubMed ID: 18975307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-1alpha treatment of meniscal explants stimulates the production and release of aggrecanase-generated, GAG-substituted aggrecan products and also the release of pre-formed, aggrecanase-generated G1 and m-calpain-generated G1-G2.
    Lemke AK; Sandy JD; Voigt H; Dreier R; Lee JH; Grodzinsky AJ; Mentlein R; Fay J; Schünke M; Kurz B
    Cell Tissue Res; 2010 Apr; 340(1):179-88. PubMed ID: 20217136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aggrecan degradation in human articular cartilage explants is mediated by both ADAMTS-4 and ADAMTS-5.
    Song RH; Tortorella MD; Malfait AM; Alston JT; Yang Z; Arner EC; Griggs DW
    Arthritis Rheum; 2007 Feb; 56(2):575-85. PubMed ID: 17265492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence of a novel aggrecan-degrading activity in cartilage: Studies of mice deficient in both ADAMTS-4 and ADAMTS-5.
    Rogerson FM; Stanton H; East CJ; Golub SB; Tutolo L; Farmer PJ; Fosang AJ
    Arthritis Rheum; 2008 Jun; 58(6):1664-73. PubMed ID: 18512787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Collagen and aggrecan degradation is blocked in interleukin-1-treated cartilage explants by an inhibitor of IkappaB kinase through suppression of metalloproteinase expression.
    Pattoli MA; MacMaster JF; Gregor KR; Burke JR
    J Pharmacol Exp Ther; 2005 Oct; 315(1):382-8. PubMed ID: 16009742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Release of hyaluronan and hyaladherins (aggrecan G1 domain and link proteins) from articular cartilage exposed to ADAMTS-4 (aggrecanase 1) or ADAMTS-5 (aggrecanase 2).
    Chockalingam PS; Zeng W; Morris EA; Flannery CR
    Arthritis Rheum; 2004 Sep; 50(9):2839-48. PubMed ID: 15457452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium pentosan polysulfate inhibits the catabolism of aggrecan in articular cartilage explant cultures.
    Munteanu SE; Ilic MZ; Handley CJ
    Arthritis Rheum; 2000 Oct; 43(10):2211-8. PubMed ID: 11037880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of long-term exposure to glucosamine and mannosamine on aggrecan degradation in articular cartilage.
    Ilic MZ; Martinac B; Handley CJ
    Osteoarthritis Cartilage; 2003 Aug; 11(8):613-22. PubMed ID: 12880584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The nutraceutical flavonoid luteolin inhibits ADAMTS-4 and ADAMTS-5 aggrecanase activities.
    Moncada-Pazos A; Obaya AJ; Viloria CG; López-Otín C; Cal S
    J Mol Med (Berl); 2011 Jun; 89(6):611-9. PubMed ID: 21365186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of protease inhibitors on the induction of osteoarthritis-related biomarkers in bovine full-depth cartilage explants.
    He Y; Zheng Q; Jiang M; Sun S; Christiansen TG; Kassem M; Karsdal MA; Bay-Jensen AC
    PLoS One; 2015; 10(4):e0122700. PubMed ID: 25909781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly sulfated glycosaminoglycans inhibit aggrecanase degradation of aggrecan by bovine articular cartilage explant cultures.
    Munteanu SE; Ilic MZ; Handley CJ
    Matrix Biol; 2002 Aug; 21(5):429-40. PubMed ID: 12225808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of glucosamine and chondroitin sulfate on bovine cartilage explants under long-term culture conditions.
    Chan PS; Caron JP; Orth MW
    Am J Vet Res; 2007 Jul; 68(7):709-15. PubMed ID: 17605605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of ADAMTS4 and MT4-MMP indicates that both are involved in aggrecanolysis in interleukin-1-treated bovine cartilage.
    Patwari P; Gao G; Lee JH; Grodzinsky AJ; Sandy JD
    Osteoarthritis Cartilage; 2005 Apr; 13(4):269-77. PubMed ID: 15780640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Research progress of a disintegrin and metalloproteinase with thrombospondin motif 4 and 5 in osteoarthritis].
    Ji Q; Zhang Q; Wang Y
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2013 Sep; 27(9):1080-4. PubMed ID: 24279019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of ADAM-TS4 (aggrecanase-1) and ADAM-TS5 (aggrecanase-2) in a model of cartilage degradation.
    Tortorella MD; Malfait AM; Deccico C; Arner E
    Osteoarthritis Cartilage; 2001 Aug; 9(6):539-52. PubMed ID: 11520168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of aggrecanases from the ADAMTS family and aggrecan neoepitope formation during in vitro chondrogenesis of human mesenchymal stem cells.
    Boeuf S; Graf F; Fischer J; Moradi B; Little CB; Richter W
    Eur Cell Mater; 2012 May; 23():320-32. PubMed ID: 22562232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-6 and its soluble receptor augment aggrecanase-mediated proteoglycan catabolism in articular cartilage.
    Flannery CR; Little CB; Hughes CE; Curtis CL; Caterson B; Jones SA
    Matrix Biol; 2000 Nov; 19(6):549-53. PubMed ID: 11068209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aggrecanase versus matrix metalloproteinases in the catabolism of the interglobular domain of aggrecan in vitro.
    Little CB; Flannery CR; Hughes CE; Mort JS; Roughley PJ; Dent C; Caterson B
    Biochem J; 1999 Nov; 344 Pt 1(Pt 1):61-8. PubMed ID: 10548534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.